On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Penn Presbyterian Medical Center

InstitutionResearch output, impact & collaborations

Penn Presbyterian Medical Center is a institution indexed in ScholarIQ from OpenAlex.

What is known about Penn Presbyterian Medical Center?

ScholarIQrecord summary

Penn Presbyterian Medical Center is a research organisation in Philadelphia, US. OpenAlex records 6,037 works and 617,955 citations for it. 1,094 researchers list it as their most recent affiliation.

How many works does Penn Presbyterian Medical Center have?

ScholarIQindexed works

Penn Presbyterian Medical Center has 6,037 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Penn Presbyterian Medical Center have?

ScholarIQcitation count

Penn Presbyterian Medical Center has 617,955 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Penn Presbyterian Medical Center?

ScholarIQresearcher count

Penn Presbyterian Medical Center has 1,094 researchers in the ScholarIQ index.

What is the average h-index at Penn Presbyterian Medical Center?

ScholarIQavg h-index

Penn Presbyterian Medical Center has an average h-index of 84.2 in OpenAlex.

What is the ROR of Penn Presbyterian Medical Center?

ScholarIQror

The ROR for Penn Presbyterian Medical Center is on the source record.

What is the OpenAlex record for Penn Presbyterian Medical Center?

ScholarIQopenalex

The OpenAlex for Penn Presbyterian Medical Center is on the source record.

What is the Wikidata of Penn Presbyterian Medical Center?

ScholarIQwikidata

The Wikidata for Penn Presbyterian Medical Center is on the source record.

Who are the most-cited researchers behind Penn Presbyterian Medical Center?

ScholarIQtop researchers by citations
1
Samuel G. Jacobson · Retinal Development and Disorders
524 works37,285 citations
2
Maureen G. Maguire · Retinal Diseases and Treatments
498 works25,578 citations
3
Artur V. Cideciyan · Retinal Development and Disorders
379 works24,683 citations
4
Jean Bennett · Retinal Development and Disorders
390 works22,855 citations
5
Wayne Huey‐Herng Sheu · Diabetes, Cardiovascular Risks, and Lipoproteins
534 works20,718 citations

What are the most-cited papers on Penn Presbyterian Medical Center?

ScholarIQmost cited works
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais, Rafael Díaz, Mark Lakshmanan, Prem Pais, Jeffrey L. Probstfield, Jeffrey S. Riesmeyer, Matthew C. Riddle, Lars Rydén, Denis Xavier, Charles Atisso, Leanne Dyal, Stephanie Hall, Rao Ps, G.C. Wong, Álvaro Avezum, Jan Basile, Namsik Chung, Ignacio Conget, William C. Cushman, Edward Franek, Nicolae Hâncu, M Hanefeld, Shaun Holt, Petr Janský, Mátyás Keltai, Fernando Laņas, Lawrence A. Leiter, Patricio López‐Jaramillo, Ernesto Muñoz, Valdis Pīrāgs, Nana Pogosova, Peter Raubenheimer, Jonathan E. Shaw, Wayne Huey‐Herng Sheu, Theodora Temelkova‐Kurktschiev, Mercedes Abella, Andrea Alebuena, Sandra Almagro, Eduardo Amoroso, Paula Anadon, Elizabeth Andreu, Guillermo Aristimuño, Maria Arzadun, María Antonietta Barbieri, Raúl Barcudi, Ines Bartolacci, Gabriel Bolobanich, Anselmo P. Bordonava, Miguel Bustamante Labarta, B. Bustos, Alberto Caccavo, Alejandra Camino, María del Rocío Cantero, Maria Carignano, Luis R Cartasegna, Marcela Cipullo, Víctor Commendatore, Victoria Conosciuto, Osvaldo Costamagna, Claudia A. Crespo, Jose Cuello, Carlos Alberto Cuneo, Sandra Cusimano, Sofia Dean, Claudio Fabián Dituro, Andrea Domínguez, Miguel Farah, Alberto Fernandez, Florencia Fernandez, Adriana Cristina Ferrari, Patricia Flammia, José Antonio Fuentealba, Karina Beatriz Gallardo, C. Perez Garcia, Ruben Garcia Duran, Marcelo Garrido, Rodolfo Gavícola, Claudio Gerbaudo, Graciela Gilli, Ana Paula Giotto, Pedro Godoy Bolzán, Oscar Gómez Vilamajó, Fernando Guerlloy, Cristian Guridi, Narcisa Gutierrez Garrido, Eduardo Hasbani, Sonia Hermida, Miguel Hominal, Adrian D. Hrabar, Adrián Ingaramo, Alejandra Izzicupo, Mario Krynski, Mariana Lagrutta, Paulina Virginia Lanchiotti, Maria Langhe, Veronica Leonard, Javier Llanos, Ricardo López Santi
The Lancet. 20193,109 CitationsOPEN ACCESS
Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65 -mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial
Stephen R. Russell, Jean Bennett, Jennifer Wellman, Daniel C. Chung, Zi-Fan Yu, Amy Tillman, Janet Wittes, Julie Pappas, Okan U. Elci, Sarah McCague, Dominique Cross, Kathleen Marshall, Jean Walshire, Taylor Kehoe, Hannah Reichert, Maria Davis, Leslie Raffini, Lindsey A. George, Fleur Hudson, Laura Dingfield, Xiaosong Zhu, Julia A. Haller, Elliott H. Sohn, Vinit B. Mahajan, Wanda Pfeifer, Michelle T. Weckmann, Chris A. Johnson, Dina Y. Gewaily, Arlene V. Drack, Edwin M. Stone, Katie Wachtel, Francesca Simonelli, Bart P. Leroy, J. Fraser Wright, Katherine A. High, Albert M. Maguire
The Lancet. 20171,923 Citations
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais, Rafael Díaz, Mark Lakshmanan, Prem Pais, Jeffrey L. Probstfield, Fady T. Botros, Matthew C. Riddle, Lars Rydén, Denis Xavier, Charles Atisso, Leanne Dyal, Stephanie Hall, Rao Ps, G.C. Wong, Álvaro Avezum, Jan Basile, Namsik Chung, Ignacio Conget, William C. Cushman, Edward Franek, Nicolae Hâncu, M Hanefeld, Shaun Holt, Petr Janský, Mátyás Keltai, Fernando Laņas, Lawrence A. Leiter, Patricio López‐Jaramillo, Ernesto Muñoz, Valdis Pīrāgs, Nana Pogosova, Peter Raubenheimer, Jonathan E. Shaw, Wayne Huey‐Herng Sheu, Theodora Temelkova‐Kurktschiev, Mercedes Abella, Andrea Alebuena, Sandra Almagro, Eduardo Amoroso, Paula Anadon, Elizabeth Andreu, Guillermo Aristimuño, Maria Arzadun, María Antonietta Barbieri, Raúl Barcudi, Ines Bartolacci, Gabriel Bolobanich, Anselmo P. Bordonava, Miguel Bustamante Labarta, B. Bustos, Alberto Caccavo, Alejandra Camino, María del Rocío Cantero, Maria Carignano, Luis R Cartasegna, Marcela Cipullo, Víctor Commendatore, Victoria Conosciuto, Osvaldo Costamagna, Claudia A. Crespo, Jose Cuello, Carlos Alberto Cuneo, Sandra Cusimano, Sofia Dean, Claudio Fabián Dituro, Andrea Domínguez, Miguel Farah, Alberto Fernandez, Florencia Fernandez, Adriana Cristina Ferrari, Patricia Flammia, José Antonio Fuentealba, Karina Beatriz Gallardo, C. Perez Garcia, Ruben Garcia Duran, Marcelo Garrido, Rodolfo Gavícola, Claudio Gerbaudo, Graciela Gilli, Ana Paula Giotto, Pedro Godoy Bolzán, Oscar Gómez Vilamajó, Fernando Guerlloy, Cristian Guridi, Narcisa Gutierrez Garrido, Eduardo Hasbani, Sonia Hermida, Miguel Hominal, Adrian D. Hrabar, Adrián Ingaramo, Alejandra Izzicupo, Mario Krynski, Mariana Lagrutta, Paulina Virginia Lanchiotti, Maria Langhe, Veronica Leonard, Javier Llanos, Ricardo López Santi
The Lancet. 2019638 CitationsOPEN ACCESS
Comparison of preschool vision screening tests as administered by licensed eye care professionals in the vision in preschoolers study*1
Paulette P. Schmidt, Maureen G. Maguire, Velma Dobson, Graham E. Quinn, Elise Ciner, Lynn Cyert, Marjean Taylor Kulp, Bruce Moore, Deborah Orel‐Bixler, Maryann Redford, Gui‐Shuang Ying
Ophthalmology. 2004288 CitationsOPEN ACCESS
Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial
Tali Cukierman‐Yaffe, Hertzel C. Gerstein, Helen M. Colhoun, Rafael Díaz, Luis‐Emilio García‐Pérez, Mark Lakshmanan, Angelyn Bethel, Denis Xavier, Jeffrey L. Probstfield, Matthew C. Riddle, Lars Rydén, Charles Atisso, Stephanie Hall, Rao Ps, Jan Basile, William C. Cushman, Edward Franek, Mátyás Keltai, Fernando Laņas, Lawrence A. Leiter, Patricio López‐Jaramillo, Valdis Pīrāgs, Nana Pogosova, Peter Raubenheimer, Jonathan E. Shaw, Wayne Huey‐Herng Sheu, Theodora Temelkova‐Kurktschiev
The Lancet Neurology. 2020278 Citations

How much of the research on Penn Presbyterian Medical Center is open access?

ScholarIQopen access share
67%OPEN ACCESS
Gold
8%
Green
25%
Hybrid
0%
Bronze
33%
Closed
33%

Related on ScholarIQ

470M+ articles · 14-day free trial